Related Experiment Video
Updated: Mar 22, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
20.7K
Thrombin Maybe Plays an Important Role in MK Differentiation into Platelets.
Xiao-Lei Yang1, Meng-Kai Ge2, De-Kui Mao2
1Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China; College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.
Biomed Research International
|April 12, 2016
Summary
Thrombin, a key blood protein, may play a role in megakaryocyte (MK) differentiation into platelets. This study found thrombin impacts MK cell markers and gene expression similarly to thrombopoietin (TPO).
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- Megakaryocytes (MKs) are essential for platelet production.
- Thrombopoietin (TPO) is a known inducer of MK differentiation.
- The role of thrombin in MK differentiation remains unclear.
Purpose of the Study:
- To investigate the effect of thrombin on MK differentiation using the Meg-01 cell line.
- To analyze morphological, functional, and molecular changes in Meg-01 cells upon thrombin treatment.
Main Methods:
- Utilized the human megakaryoblastic leukemia cell line (Meg-01).
- Assessed changes in cell morphology and function.
- Analyzed the expression of key differentiation markers and regulatory factors.
Main Results:
- Thrombin suppressed Meg-01 cell proliferation, induced apoptosis, and caused cell cycle arrest.
- Thrombin upregulated the expression of MK markers CD41b and the transcription factor GATA-1.
- Thrombin downregulated B-cell lymphoma 2 (Bcl-2) and upregulated p-AKT and p-ERK, mimicking TPO effects.
Conclusions:
- Data suggest thrombin may significantly contribute to MK differentiation into platelets.
- Further research is needed to confirm if thrombin-induced particles are indeed functional platelets.
Related Concept Videos
01:18Structure and Function of Platelets
4.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.6K
01:22Formation of the Platelet Plug
10.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.1K
01:16Clot Retraction and Fibrinolysis
10.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K